✦ LIBER ✦

Prophylactic treatment of migraine with tolfenamic acid : A COMPARATIVE DOUBLE-BLIND CROSSOVER STUDY BETWEEN TOLFENAMIC ACID AND PLACEBO

✍ Scribed by Bjarne Majlund Mikkelsen; Jørgen Viggo Falk

Book ID: 114781353
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 355 KB
Volume: 66
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1982.tb03134.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylactic treatment of migraine with

Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo

✍ B. Mikkelsen; K. Kjærsgaard Pedersen; L. V. Christiansen 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB

Tolfenamic Acid in Acute and Prophylacti

Tolfenamic Acid in Acute and Prophylactic Treatment of Migraine: A Review

✍ Hansen, Per Evald 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Botulinum toxin A in the prophylactic tr

Botulinum toxin A in the prophylactic treatment of migraine – a randomized, double-blind, placebo-controlled study

✍ S Evers; J Vollmer-Haase; S Schwaag; A Rahmann; I-W Husstedt; A Frese 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Botulinum Toxin Type A Prophylactic Trea

Botulinum Toxin Type A Prophylactic Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Exploratory Study

✍ Sheena K. Aurora; Marek Gawel; Jan L. Brandes; Suriani Pokta; Amanda M. VanDenbu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

Long-term treatment of latent portosyste

Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids: A double-blind placebo-controlled crossover study

✍ Mathias Plauth; Eick-Hartwig Egberts; Wolfgang Hamster; Maria Török; Peter H. Mü 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 550 KB

Double-blind, placebo-controlled crossov

Double-blind, placebo-controlled crossover study of folinic acid (Leucovorin®) for the treatment of fragile X syndrome

✍ Strom, Charles M. ;Brusca, Rita M. ;Pizzi, William J. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

## Abstract We conducted a randomized, double‐blind, placebo‐controlled crossover study of folinic acid therapy (dl‐Leucovorin®, 15 mg/day) or placebo for males with Fragile X (fra(x)) syndrome. Twenty‐one patients were enrolled in the study. The treatment periods were 3 months in length. Patients